Sanofi-aventis Revenue and Competitors

Bridgewater, NJ USA

Location

N/A

Total Funding

Pharma

Industry

Estimated Revenue & Valuation

  • Sanofi-aventis's estimated annual revenue is currently $41.6M per year.(i)
  • Sanofi-aventis's estimated revenue per employee is $201,000

Employee Data

  • Sanofi-aventis has 207 Employees.(i)
  • Sanofi-aventis grew their employee count by -10% last year.

Sanofi-aventis's People

NameTitleEmail/Phone
1
Head - Customer ServiceReveal Email/Phone
2
Head Performance & Process Innovation, SBS CI2C EUReveal Email/Phone
3
VP, Evidence Based MedicineReveal Email/Phone
4
Global Safety Officer, Sr Director, Diabetes & Cardiovascular Unit; Global PharmacovigilanceReveal Email/Phone
5
Strategy and Partnering, Director Digital AlliancesReveal Email/Phone
6
Senior Manager - MSATReveal Email/Phone
7
Submission ManagerReveal Email/Phone
8
Senior Principal PlannerReveal Email/Phone
9
Medical portfolio managementReveal Email/Phone
10
Sample Operations Quality and Continuous ImprovementReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$5M25-11%N/AN/A
#2
$35.8M1788%N/AN/A
#3
$5.4M27-25%N/AN/A
#4
$4180M145161%$550MN/A
#5
$12.5M6215%N/AN/A
#6
$6.7M119-37%$199.6MN/A
#7
$9.4M477%N/AN/A
#8
$10.3M516%N/AN/A
#9
$106.3M52916%N/AN/A
#10
$15.5M7720%N/AN/A
Add Company

What Is Sanofi-aventis?

Sanofi-Aventis U.S. LLC is a pharmaceuticals company based out of 55 Corporate Dr, Bridgewater, New Jersey, United States.

keywords:N/A

N/A

Total Funding

207

Number of Employees

$41.6M

Revenue (est)

-10%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Sanofi-aventis News

2022-04-20 - Artesunate Tablet Market Growth and Demands Analysis from ...

Artesunate Tablet Market Growth and Demands Analysis from 2022-2028 | Fosun Pharma (Guilin), Ipca Laboratories, Sanofi Aventis.

2022-04-19 - Global Biopharmaceuticals Market 2022 Business ...

Roche; Amgen; AbbVie; Sanofi-Aventis; Johnson & Johnson; Pfizer; Novo Nordisk; Eli Lilly; Novartis; Merck; Sun; 3sbio; Changchun High Tech...

2022-03-30 - Sanofi-aventis Reports Expanded Approval Of Dupixent In Canada To Include Children Aged Six To 11

(RTTNews) - Sanofi-aventis Canada Inc. announced the expanded approval of Dupixent as an add-on maintenance treatment in patients aged six...

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$61.6M2235%N/A
#2
$61.8M224-5%N/A
#3
$36.2M274-10%N/A
#4
$84.6M285-1%N/A
#5
$58M2939%N/A